𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of intrastriatal blockade of glutamatergic transmission on the acquisition of T-maze and radial maze tasks

✍ Scribed by W. Hauber; W. J. Schmidt

Publisher
Springer
Year
1989
Tongue
English
Weight
969 KB
Volume
78
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of pramiracetam (CI-879) on t
The effect of pramiracetam (CI-879) on the acquisition of a radial arm maze task
✍ C. L. Murray; H. C. Fibiger πŸ“‚ Article πŸ“… 1986 πŸ› Springer 🌐 English βš– 381 KB

The effect of the nootropic drug pramiracetam (CI-879) on acquisition of a radial arm maze task was examined in the rat. Two doses of pramiracetam (7.5 mg/kg and 15 mg/kg) were administered daily prior to testing for 7 weeks in a 16-arm radial maze in which nine arms were baited with food. This proc

Hippocampal lesions and discrimination p
Hippocampal lesions and discrimination performance of mice in the radial maze: Sparing or impairment depending on the representational demands of the task
✍ Nicole Etchamendy; Aline Desmedt; Cedric Cortes-Torrea; Aline Marighetto; Robert πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 778 KB

## Abstract The effects of ibotenate hippocampal lesions on discrimination performance in an eight‐arm radial maze were investigated in mice, using a three‐stage paradigm in which the only parameter that varied among stages was the way the arms were presented. In the initial learning phase (stage 1

Bridged nicotine, isonicotine, and noris
Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze
✍ Edward D. Levin; M. Imad Damaj; William Glassco; Everett L. May; Billy R. Martin πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

Nicotine and other nicotinic agonists have been found to improve performance in a variety of tasks, including the radial-arm maze to improve memory. There has been an active effort to develop novel nicotinic agonists for the treatment of cognitive dysfunction such as is seen in Alzheimer's disease.